Innovating Works

UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-...

Desconocido
VASA: Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield anti schi... UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO participó en un H2020: H2020-SC1-BHC-2018-2020 Schistosomiasis is a poverty-related neglected tropical disease, impacting one billion people in 74 countries. Science ranked a schistosomia...
2019-05-06 - 2026-03-31 | Financiado
Vacc-iNTS: Advancing a GMMA based vaccine against invasive non typhoidal salmonellosis through Phase 1 trial in... Invasive non-typhoidal Salmonellosis (iNTS) is an important emerging Neglected Infectious Disease in resource-poor settings of sub-Saharan A...
2019-04-30 - 2026-07-31 | Financiado
DEMOSTAF: Emerging population issues in sub Saharan Africa Cross checking and promoting demographic data for... UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO participó en un H2020: H2020-MSCA-RISE-2015 DEMOSTAF (DEMOgraphy-STatistics-for-Africa) brings together European and African research institutes as well as non academic African nationa...
2015-12-09 - 2019-12-31 | Financiado
CLUVA: CLimate change and Urban Vulnerability in Africa UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO participó en un FP7: The social and economic impact of natural disasters in emerging economies and developing countries is growing. Many African countries have f...
Financiado
APARET: African Programme for Advanced Research Epidemiology Training UNIVERSITE OUAGA I PROFESSEUR JOSEPH KI-ZERBO participó en un FP7: The APARET fellowship programme will catalyse independent research activities of graduates of Field Epidemiology Training Programmes (FETP)...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.